BioAtla, Inc.BCABNASDAQ

Revenue (LTM)

$11M

Net Income (LTM)

$-70M

+43.5% YoY

Free Cash Flow

$-72M

Revenue CAGR (5Y)

+16.2%

Marginsimproving

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0↓41.7%	0	0	11
Gross Profit	-20	0↑101.3%	-1↓579.6%	-1↓1.8%	10↑925.1%
Operating Income	-30	-96↓220.4%	-108↓12.1%	-130↓19.9%	-74↑43.0%
Net Income	-36	-95↓166.1%	-105↓10.4%	-123↓17.3%	-70↑43.5%
EBITDA	-33	-94↓181.2%	-105↓11.9%	-122↓16.1%	-73↑40.3%
EPS Diluted	-1.06	-2.76↓160.4%	-2.74↑0.7%	-2.58↑5.8%	-1.44↑44.2%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	239	245↑2.7%	216↓12.0%	111↓48.3%	49↓56.0%
Total Current Assets	241	247↑2.7%	220↓10.9%	116↓47.2%	51↓56.0%
Total Assets	245	254↑3.9%	226↓11.3%	120↓47.0%	52↓56.2%
Total Current Liabilities	32	20↓38.6%	23↑16.7%	28↑22.5%	15↓48.7%
Total Liabilities	35	44↑24.7%	45↑4.1%	49↑7.9%	38↓22.1%
Total Equity	210	211↑0.4%	180↓14.5%	71↓60.8%	14↓79.8%
Total Debt	1	5↑687.5%	4↓25.9%	2↓38.2%	1↓66.0%
Net Debt	-238	-240↓0.7%	-212↑11.7%	-109↑48.5%	-48↑55.8%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-36	-62↓71.2%	-90↓45.3%	-104↓15.0%	-72↑30.8%
Capital Expenditure	-1	-1↓56.6%	-0↑71.0%	-0↑63.4%	0
Free Cash Flow	-37	-63↓71.0%	-91↓43.6%	-104↓14.8%	-72↑30.9%
Stock-Based Comp	3	25↑731.1%	15↓42.0%	14↓7.0%	9↓34.1%
Net Change in Cash	235	6↓97.3%	-29↓562.4%	-104↓253.0%	-62↑40.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance